RxResults - 3x3x3 Challenge with LG Hanzel
RxResults, the proven industry leader for evidence-based pharmacy risk management, empowers plan sponsors with informatics, clinical expertise & process execution for formulary & specialty drug management. RxResults doesn't replace the PBM, it serves to enhance the PBM model as an advocate for the plan & plan participants.
Transcription:
What is RxResults?
First of all, RxResults takes on the role of what we call a pharmacy risk manager. We act as an advocate for both the plan sponsor and for the plan participants. And in that role, we offer a couple of different solutions. Our solutions really tackle specialty drug spending at the employer level, and that's high on a lot of radars these days, as well as managing the formulary in a more optimized strategy, meaning that a lot of the current PBM model today, Chris, is focused on maximizing rebates. And what we're looking at is how do you get to the lowest net cost on your formulary as well? But again, we bring that independent team of pharmacists, benefit industry experts, and then just a lot of expertise around data, and analytics, and clinical expertise.
How is RxResults different?
Our model's really unique. No one else in the industry has this model. We are actually a joint collaborative with the University of Arkansas for Medical Sciences. We work closely with the College of Pharmacy. We've got our own independent P and T committee that meets on a monthly basis, they do 100s of drug reviews annually, and really looking again, not only at the clinical safety and the clinical efficacy of these drugs, but also looking at price points so that you've got some control around the spend as well.
Who is a good fit for RxResults?
We have a lot of success across self-insured employers, multiple industry segments. Most of our conversations, as you can see here, start with data, what we call a data journey or a pharmacy risk analysis. And when we run this analysis, we're taking the employer's actual claims data and saying, "Had RxResults been in place, what impact would we have had both on the specialty spend of the plan and then also on the formulary component or the maintenance meds that are out there as well?" And you can see when we look at this, be it a health system where there's 3.2 million in potential savings sitting out there, or a school district with a 600,000 in savings, financial services and or manufacturers, there're just a lot of opportunities to fine-tune the pharmacy benefit plan and get that additional savings in place.
Transcription:
What is RxResults?
First of all, RxResults takes on the role of what we call a pharmacy risk manager. We act as an advocate for both the plan sponsor and for the plan participants. And in that role, we offer a couple of different solutions. Our solutions really tackle specialty drug spending at the employer level, and that's high on a lot of radars these days, as well as managing the formulary in a more optimized strategy, meaning that a lot of the current PBM model today, Chris, is focused on maximizing rebates. And what we're looking at is how do you get to the lowest net cost on your formulary as well? But again, we bring that independent team of pharmacists, benefit industry experts, and then just a lot of expertise around data, and analytics, and clinical expertise.
How is RxResults different?
Our model's really unique. No one else in the industry has this model. We are actually a joint collaborative with the University of Arkansas for Medical Sciences. We work closely with the College of Pharmacy. We've got our own independent P and T committee that meets on a monthly basis, they do 100s of drug reviews annually, and really looking again, not only at the clinical safety and the clinical efficacy of these drugs, but also looking at price points so that you've got some control around the spend as well.
Who is a good fit for RxResults?
We have a lot of success across self-insured employers, multiple industry segments. Most of our conversations, as you can see here, start with data, what we call a data journey or a pharmacy risk analysis. And when we run this analysis, we're taking the employer's actual claims data and saying, "Had RxResults been in place, what impact would we have had both on the specialty spend of the plan and then also on the formulary component or the maintenance meds that are out there as well?" And you can see when we look at this, be it a health system where there's 3.2 million in potential savings sitting out there, or a school district with a 600,000 in savings, financial services and or manufacturers, there're just a lot of opportunities to fine-tune the pharmacy benefit plan and get that additional savings in place.